209
Views
13
CrossRef citations to date
0
Altmetric
Original article

Angiotensin‐receptor blockers and diuretics—Advantages of combination

&
Pages 6-11 | Received 28 Apr 2004, Accepted 16 Nov 2004, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

David T. Nash, Nora Crikelair & Dion Zappe. (2008) Achieving BP goals with valsartan and HCTZ alone and in combination: pooled analysis of two randomized, double-blind, placebo-controlled studies. Current Medical Research and Opinion 24:9, pages 2617-2626.
Read now
J. Akram, U. E. Sheikh, M. Mahmood & R. Donnelly. (2007) Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy: the NATIVE study. Current Medical Research and Opinion 23:12, pages 2929-2936.
Read now
Thomas Hedner, Sverre E. Kjeldsen & Krzysztof Narkiewicz. (2006) RAAS inhibition – a practice of medical progress. Blood Pressure 15:sup1, pages 5-6.
Read now

Articles from other publishers (10)

Elena Filipova, Stela Dineva, Katya Uzunova, Velichka Pavlova, Krassimir Kalinov & Toni Vekov. (2020) Combining angiotensin receptor blockers with chlorthalidone or hydrochlorothiazide – which is the better alternative? A meta-analysis. Systematic Reviews 9:1.
Crossref
Adrián Noriega de la Colina, Rong Wu, Laurence Desjardins-Crépeau, Atef Badji, Maxime Lamarre-Cliche, Julien Doyon, Louis Bherer & Hélène Girouard. (2019) Diurnal blood pressure loads are associated with lower cognitive performances in controlled-hypertensive elderly individuals. Journal of Hypertension 37:11, pages 2168-2179.
Crossref
Andreas P. Kalogeropoulos, Clive Goulbourne & Javed Butler. (2019) Diagnosis and Prevention of Hypertensive Heart Failure. Heart Failure Clinics 15:4, pages 435-445.
Crossref
Nicholas Ekow ThomfordKevin DzoboEmile ChimusaKerstin Andrae-MarobelaShadreck ChirikureAmbroise WonkamCollet Dandara. (2018) Personalized Herbal Medicine? A Roadmap for Convergence of Herbal and Precision Medicine Biomarker Innovations. OMICS: A Journal of Integrative Biology 22:6, pages 375-391.
Crossref
Melvin R. Hayden & James R. Sowers. (2008) Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndrome. Journal of the American Society of Hypertension 2:4, pages 239-266.
Crossref
Biff F Palmer. (2008) Improving BP Control with Combined Renin-Angiotensin System Blockade and Thiazide Diuretics in Hypertensive Patients with Diabetes Mellitus or Kidney Disease. American Journal of Cardiovascular Drugs 8:1, pages 9-14.
Crossref
Matthew R. Weir, Nora Crikelair, Drew Levy, Ricardo Rocha, Venkatram Kuturu & Robert Glazer. (2007) Evaluation of the Dose Response With Valsartan and Valsartan/Hydrochlorothiazide in Patients With Essential Hypertension. The Journal of Clinical Hypertension 9:2, pages 103-112.
Crossref
Benjamin J Epstein, Katherine Vogel & Biff F Palmer. (2007) Dihydropyridine Calcium Channel Antagonists in the Management of Hypertension. Drugs 67:9, pages 1309-1327.
Crossref
Claudio Borghi, Sibel Ertek & Arrigo FG Cicero. (2006) Irbesartan: a review of its use alone and in combination with hydrochlorothiazide. Therapy 3:6, pages 733-749.
Crossref
Craig S. Stump, Marc T. Hamilton & James R. Sowers. (2006) Effect of Antihypertensive Agents on the Development of Type 2 Diabetes Mellitus. Mayo Clinic Proceedings 81:6, pages 796-806.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.